---
title: "R J Bio-Tech Ltd (536456) — Share Price, Financials & Analysis"
symbol: "536456"
company: "R J Bio-Tech Ltd"
canonical: "https://tapetide.com/stocks/536456"
isin: "INE594O01015"
bse_code: "536456"
sector: "Fast Moving Consumer Goods"
industry: "Agricultural Food & other Products"
generated_at: "2026-09-13T19:43:20.142Z"
---

# R J Bio-Tech Ltd (536456)

Canonical page: https://tapetide.com/stocks/536456

## Company

- **BSE Code:** 536456
- **ISIN:** INE594O01015
- **Sector:** Fast Moving Consumer Goods
- **Industry:** Agricultural Food & other Products
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2013-09-25
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** rjbiotech.com

## About

Incorporated in 2005, R J Biotech Limited develops proprietary hybrids with nutritional and economical traits in Fiber crops, Cereal crops and Vegetable crops

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 99% | 26% | 15% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7 | 2 | 15 | 11 | 6 | 4 | 0 | 0 | 0 | 7 | 0 | 2 |
| Expenses | 6 | 2 | 13 | 7 | 4 | 6 | 0 | 11 | 0 | 9 | 0 | 8 |
| Operating Profit | 2 | 0 | 2 | 4 | 2 | -3 | 0 | -11 | 0 | -1 | 0 | -6 |
| OPM % | 21 | -22 | 16 | 37 | 33 | -73 | — | -11922 | — | -20 | 100 | -374 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 0 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | -2 | 1 | 3 | 1 | -4 | 0 | -13 | 0 | -3 | 0 | -17 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | — | 0 | — | 0 |
| Net Profit | 1 | -2 | 1 | 3 | 1 | -4 | 0 | -13 | 0 | -3 | 0 | -17 |
| EPS in Rs | 0.67 | -1.84 | 1.55 | 3.36 | 1.21 | -3.74 | 0 | -13.54 | 0 | -3.54 | 0 | -18.39 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 24.63 | 29.69 | 11.91 | 7.04 | 7.73 | 10.21 | 12.65 | 11.34 | 0 | 0 |
| Expenses | 18.86 | 23.53 | 23.07 | 14.93 | 15.11 | 13.7 | 25.27 | 10.02 | 0.79 | 0.01 |
| Operating Profit | 5.77 | 6.16 | -11.16 | -7.89 | -7.38 | -3.49 | -12.62 | 1.32 | -0.79 | -0.01 |
| OPM % | 23.43 | 20.75 | -93.7 | -112.07 | -95.47 | -34.18 | -99.76 | 11.64 | — | — |
| Other Income | 0 | 0 | 0.06 | -8.69 | 0.14 | 0.21 | -2.97 | 0.52 | 0.55 | 0 |
| Interest | 3.6 | 3.44 | 3.6 | 3.89 | 4.14 | 0.78 | 0 | 5.82 | 0 | 0 |
| Depreciation | 0.7 | 0.44 | 0.32 | 0.3 | 0.15 | 0.1 | 0.09 | 0.07 | 0.01 | 0.01 |
| Profit before tax | 1.47 | 2.28 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.02 |
| Tax % | 0 | 0.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1.46 | 2.27 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.01 |
| EPS in Rs | 1.54 | 2.4 | -15.86 | -21.94 | -12.18 | -4.39 | -16.56 | -4.28 | -0.26 | -0.01 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | — | — |
| Reserves | 14.23 | 16.5 | 1.49 | -19.28 | -30.81 | -34.97 | -50.65 | -59.81 | — | — |
| Borrowings | 26.81 | 24.86 | 29.63 | 37.25 | 41.5 | 42.1 | 40.54 | 51.14 | — | — |
| Other Liabilities | 10.36 | 9.06 | 6.94 | 7.64 | 7.62 | 8.82 | 6.5 | 1.11 | — | — |
| Total Liabilities | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |
| Fixed Assets | 2.41 | 2.12 | 1.95 | 1.84 | 1.75 | 1.72 | 1.75 | 1.53 | — | — |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Other Assets | 58.46 | 57.77 | 45.58 | 33.24 | 26.03 | 23.7 | 4.11 | 0.38 | — | — |
| Total Assets | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.47 | 5.79 | 0.07 | -2.69 | 0.84 | 0.71 | 1.96 | -4.72 | 0.7 | -0.8 |
| Cash from Investing Activity | -1.66 | -1.35 | -0.84 | -0.82 | -0.77 | -0.67 | -0.37 | 0 | 0.09 | 0 |
| Cash from Financing Activity | -0.95 | -4.84 | 0.82 | 3.45 | -0.03 | -0.06 | -1.54 | 4.68 | 0 | 0 |
| Net Cash Flow | -0.14 | -0.4 | 0.05 | -0.05 | 0.04 | -0.02 | 0.05 | -0.04 | 0.79 | -0.8 |
| Free Cash Flow | 2.35 | 5.76 | 0.09 | -2.77 | 0.78 | 0.64 | 1.85 | -4.72 | 0.79 | -0.8 |
| CFO/OP | 43 | 94 | -1 | 34 | -11 | -20 | -16 | -386 | -89 | 8000 |

### Ratios

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 238.15 | 294.07 | 581.67 | 862.73 | 473.13 | 263.47 | 23.95 | 9.01 | — | — |
| Inventory Days | 1367.74 | 765.29 | 688.99 | 636.64 | 798.33 | 836.97 | 30.46 | 0 | — | — |
| Days Payable | 107.48 | 63.88 | 54.78 | 157.17 | 150.67 | 170.45 | 11.6 | — | — | — |
| Cash Conversion Cycle | 1498.4 | 995.47 | 1215.88 | 1342.2 | 1120.79 | 929.99 | 42.8 | 9.01 | — | — |
| Working Capital Days | 318.17 | 275.5 | 281.95 | -389.89 | -891.96 | -820.09 | -1129.05 | -1547.23 | — | — |
| ROCE % | 10.39 | 11.29 | -25.11 | -23.67 | -31.05 | -18.88 | -159.27 | 2400 | — | — |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.32% |
| Public | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.68% |
| No. of Shareholders | 205 | 213 | 216 | 218 | 223 | 245 |

### Quarterly

| Category | Dec 2016 | Mar 2017 | Sep 2017 | Mar 2018 | Sep 2018 | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.29% | 60.32% | 60.32% |
| Public | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.71% | 39.68% | 39.68% |
| No. of Shareholders | 198 | 205 | 215 | 213 | 213 | 216 | 216 | 218 | 217 | 223 | 234 | 245 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 3.64 | Sell |
| EMA (10) | 3.63 | Sell |
| SMA (20) | 4.1 | Sell |
| EMA (20) | 3.9 | Sell |
| SMA (50) | 4.3 | Sell |
| EMA (50) | 4.53 | Sell |
| SMA (100) | 5.67 | Sell |
| EMA (100) | 5.68 | Sell |
| SMA (200) | 7.31 | Sell |
| EMA (200) | 9.42 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 32.98 | Neutral |
| MACD (12,26,9) | -0.33 | Sell |
| Stochastic (14,3,3) | 12.77 | Buy |
| ADX (14) | 31.04 | Buy |
| Williams %R (14) | -77.46 | Neutral |
| ATR (14) | 0.15 | High Volatility |
| ROC (12) | -24.28 | Sell |
| Stoch RSI (14) | 28.86 | Neutral |
| UO (7,14,28) | 30.88 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - Board meeting on 13 Feb 2026 to approve Q3/9M unaudited results ended 31 Dec 2025; trading window remains closed. | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025. 6 Feb - Board meeting on 13 Feb 2026 to approve Q3/9M unaudited results ended 31 Dec 2025; trading window remains closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61ba5ec0-77ea-4576-81d3-b48a3265e48e.pdf) |
| 27 Jan 2025 - Resignation of multiple directors and CFO due to liquidation. | [Announcement under Regulation 30 (LODR)-Change in Management 27 Jan 2025 - Resignation of multiple directors and CFO due to liquidation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/deb4fcfa-8bfe-4227-8ceb-6feff03944c8.pdf) |
| 27 Jan 2025 - Change in management and directorship due to liquidation. | [Announcement under Regulation 30 (LODR)-Change in Management 27 Jan 2025 - Change in management and directorship due to liquidation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d08ba018-155c-4b93-a546-dbafc6643308.pdf) |
| 26 Oct 2024 - Confirmation of sale of RJ Biotech Limited as a going concern. | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 26 Oct 2024 - Confirmation of sale of RJ Biotech Limited as a going concern.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b54f0e1-896a-4a23-86b9-09b79c5c34f2.pdf) |
| 25 Oct 2024 - Confirmation of sale of RJ Biotech Limited in liquidation. | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 25 Oct 2024 - Confirmation of sale of RJ Biotech Limited in liquidation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c44dc7c9-b096-4a6c-8e0d-4622778b6d1d.pdf) |
| 19 Feb - Copies Newspaper Advertisement(s) of Notice regarding Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Feb - Copies Newspaper Advertisement(s) of Notice regarding Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7367fddd-e2a9-4eed-acef-6b7d556945f1.pdf) |
| 13 Jan - PDK Impex withdrew Rs.10.22 crore Section 7 IBC petition; dismissed by NCLT Kolkata on Jan 13, 2026. | [Update 13 Jan - PDK Impex withdrew Rs.10.22 crore Section 7 IBC petition; dismissed by NCLT Kolkata on Jan 13, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac7b7a31-01dd-4bf7-a607-9f646cdb2687.pdf) |
| 13 Feb - Unaudited Q3/9M results approved; auditor adverse review cites Rs.2,86,050 lakh ICDs, going-concern uncertainty and large debt exposure. | [Board Meeting Outcome for Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025. 13 Feb - Unaudited Q3/9M results approved; auditor adverse review cites Rs.2,86,050 lakh ICDs, going-concern uncertainty and large debt exposure.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e58b2dac-9e2e-436e-ab4c-699ff771a6bf.pdf) |
| 13 Feb - Approved unaudited results for quarter/nine months ended Dec 31, 2025; auditors flagged going-concern, ICDs Rs.2,76,109 lakhs | [Unaudited Financial Results For Quarter Ended 31.12.2025 13 Feb - Approved unaudited results for quarter/nine months ended Dec 31, 2025; auditors flagged going-concern, ICDs Rs.2,76,109 lakhs](https://www.bseindia.com/xml-data/corpfiling/AttachHis/66f5eb47-3652-4a1b-9ff3-62572ade9f8b.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6564852d-a8eb-40a5-9a71-b9660a6164fd.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2025-01-27 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d08ba018-155c-4b93-a546-dbafc6643308.pdf) |
| 2025-01-27 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=deb4fcfa-8bfe-4227-8ceb-6feff03944c8.pdf) |
| 2024-10-26 | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b54f0e1-896a-4a23-86b9-09b79c5c34f2.pdf) |
| 2024-10-25 | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c44dc7c9-b096-4a6c-8e0d-4622778b6d1d.pdf) |
| 2024-07-19 | [Financial Results For The Period Ended On 31St March,2023 And 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497e79e7-aa35-45b7-bc99-150f8612716a.pdf) |
| 2024-07-19 | [Financial Results For The Period Ended On 31St March,2023 And 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3944961-b1c6-4f25-9386-f6b85ad5825c.pdf) |
| 2024-07-18 | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2f075b3-859b-40be-9f4a-e143416d795b.pdf) |
| 2024-07-17 | [Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73d4dded-b0a6-4652-8557-dc0731c7272b.pdf) |
| 2024-07-10 | [Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8703abc4-c999-4fad-892f-c79e1073ec95.pdf) |
| 2024-07-09 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7ca17db-89fb-445f-a4c5-f97cfbcedd2b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bb7d0c4a-a086-4350-8762-35fba4516d91.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7f513a1-51d0-46fa-a64c-dd53968c0550.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/97bde84e-38c3-44f2-9fce-59b8eaa898e3.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532654/76827532654.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/536456/74908536456.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532654/72775532654.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/536456/72380536456.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532654/68071532654.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/536456/65771536456.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532654/5326540319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:43:20.142Z.